EKF Diagnostics Holdings plc said it repurchased 60,000 of its own ordinary shares on Tuesday at a weighted average price of 25 pence per share.
The transactions were executed in two tranches: 50,000 shares were bought at 13:17 at 25p each, followed by 10,000 shares at 21:35 at the same price. All repurchased shares will be cancelled, with no shares held in treasury.
As a result, EKF’s total issued share capital will fall to 428,268,112 ordinary shares of 1p each, according to a filing to the UK’s Financial Conduct Authority. The move reduces the company’s total voting rights to 428,268,112, a figure that shareholders may use as a reference for Disclosure and Transparency Rules notifications.
The diagnostics group, headquartered in Penarth, Wales, operates five manufacturing facilities in the United States and Germany and sells products in more than 120 countries. EKF specializes in point-of-care analyzers for hematology and diabetes, as well as life sciences services. Its shares are listed on London’s AIM market under the ticker EKF.
